Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spectrum Analysis | 5 | 2024 | 29 | 2.210 |
Why?
|
| Tomography, Optical | 14 | 2014 | 22 | 2.200 |
Why?
|
| Fiber Optic Technology | 5 | 2015 | 14 | 1.590 |
Why?
|
| Photons | 6 | 2013 | 27 | 1.480 |
Why?
|
| Liver | 3 | 2018 | 415 | 1.430 |
Why?
|
| Models, Theoretical | 8 | 2018 | 129 | 1.420 |
Why?
|
| Image Enhancement | 9 | 2010 | 57 | 1.360 |
Why?
|
| Tomography, Optical Coherence | 6 | 2007 | 89 | 1.320 |
Why?
|
| Diffusion | 8 | 2018 | 37 | 1.260 |
Why?
|
| Low-Level Light Therapy | 2 | 2019 | 9 | 1.250 |
Why?
|
| Scattering, Radiation | 6 | 2018 | 28 | 1.200 |
Why?
|
| Adipose Tissue | 2 | 2017 | 179 | 0.980 |
Why?
|
| Spectrophotometry, Infrared | 4 | 2007 | 25 | 0.860 |
Why?
|
| Infrared Rays | 6 | 2015 | 23 | 0.850 |
Why?
|
| Radiometry | 2 | 2019 | 44 | 0.780 |
Why?
|
| Algorithms | 11 | 2013 | 419 | 0.740 |
Why?
|
| Tomography | 4 | 2003 | 17 | 0.700 |
Why?
|
| Ultrasonography, Doppler | 3 | 2005 | 22 | 0.670 |
Why?
|
| Spinal Canal | 1 | 2019 | 1 | 0.660 |
Why?
|
| Fatty Liver | 2 | 2018 | 49 | 0.640 |
Why?
|
| Computer Simulation | 10 | 2018 | 221 | 0.630 |
Why?
|
| Transplants | 1 | 2018 | 3 | 0.630 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 20 | 0.620 |
Why?
|
| Optical Imaging | 1 | 2018 | 28 | 0.610 |
Why?
|
| Optical Phenomena | 3 | 2012 | 5 | 0.610 |
Why?
|
| Peritoneal Cavity | 1 | 2017 | 13 | 0.590 |
Why?
|
| Liver Transplantation | 1 | 2018 | 51 | 0.590 |
Why?
|
| Veins | 1 | 2017 | 19 | 0.580 |
Why?
|
| Spinal Cord Diseases | 1 | 2018 | 30 | 0.580 |
Why?
|
| Light | 5 | 2018 | 117 | 0.560 |
Why?
|
| Arteries | 1 | 2017 | 65 | 0.560 |
Why?
|
| Image Interpretation, Computer-Assisted | 6 | 2010 | 107 | 0.540 |
Why?
|
| Kidney | 1 | 2018 | 274 | 0.540 |
Why?
|
| Dogs | 7 | 2019 | 504 | 0.540 |
Why?
|
| Lighting | 2 | 2007 | 9 | 0.530 |
Why?
|
| Venereal Tumors, Veterinary | 3 | 2011 | 6 | 0.520 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2015 | 3 | 0.520 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2015 | 72 | 0.510 |
Why?
|
| Optics and Photonics | 3 | 2003 | 23 | 0.490 |
Why?
|
| Muscle, Skeletal | 2 | 2024 | 578 | 0.470 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2014 | 10 | 0.470 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 246 | 0.460 |
Why?
|
| Hyperthermia, Induced | 2 | 2014 | 30 | 0.450 |
Why?
|
| Blood Flow Velocity | 3 | 2004 | 63 | 0.450 |
Why?
|
| Animals | 14 | 2024 | 9954 | 0.440 |
Why?
|
| Duodenum | 1 | 2013 | 15 | 0.440 |
Why?
|
| Models, Chemical | 2 | 2013 | 88 | 0.440 |
Why?
|
| Magnetite Nanoparticles | 1 | 2013 | 15 | 0.430 |
Why?
|
| Pancreas | 1 | 2013 | 58 | 0.430 |
Why?
|
| Fluorescence | 1 | 2013 | 47 | 0.430 |
Why?
|
| Models, Biological | 1 | 2015 | 446 | 0.420 |
Why?
|
| Artifacts | 2 | 2011 | 49 | 0.370 |
Why?
|
| Sensitivity and Specificity | 8 | 2015 | 509 | 0.360 |
Why?
|
| Equipment Failure Analysis | 6 | 2007 | 36 | 0.350 |
Why?
|
| Equipment Design | 7 | 2007 | 211 | 0.350 |
Why?
|
| Prostate | 4 | 2011 | 51 | 0.330 |
Why?
|
| Ultrasound, High-Intensity Focused, Transrectal | 1 | 2009 | 4 | 0.330 |
Why?
|
| Dog Diseases | 1 | 2009 | 28 | 0.330 |
Why?
|
| Refractometry | 3 | 2018 | 6 | 0.320 |
Why?
|
| Swine | 3 | 2017 | 220 | 0.310 |
Why?
|
| Cadaver | 2 | 2019 | 57 | 0.310 |
Why?
|
| Interferometry | 1 | 2007 | 11 | 0.300 |
Why?
|
| Time | 1 | 2007 | 16 | 0.300 |
Why?
|
| Skin | 2 | 2019 | 140 | 0.290 |
Why?
|
| Reproducibility of Results | 8 | 2015 | 748 | 0.290 |
Why?
|
| Photoplethysmography | 1 | 2007 | 1 | 0.280 |
Why?
|
| Oximetry | 1 | 2007 | 10 | 0.280 |
Why?
|
| Endoscopes | 1 | 2006 | 6 | 0.280 |
Why?
|
| Microscopy, Video | 1 | 2005 | 18 | 0.260 |
Why?
|
| Radionuclide Imaging | 1 | 2005 | 56 | 0.250 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2005 | 26 | 0.250 |
Why?
|
| Hemorheology | 1 | 2005 | 7 | 0.240 |
Why?
|
| Monte Carlo Method | 2 | 2018 | 61 | 0.240 |
Why?
|
| Positron-Emission Tomography | 1 | 2005 | 98 | 0.230 |
Why?
|
| Atherosclerosis | 1 | 2005 | 91 | 0.230 |
Why?
|
| Calibration | 3 | 2018 | 28 | 0.230 |
Why?
|
| Anisotropy | 2 | 2018 | 19 | 0.230 |
Why?
|
| Red Meat | 1 | 2024 | 2 | 0.230 |
Why?
|
| Ultrasonics | 1 | 2003 | 7 | 0.220 |
Why?
|
| Myoglobin | 1 | 2024 | 32 | 0.220 |
Why?
|
| Finite Element Analysis | 3 | 2013 | 45 | 0.220 |
Why?
|
| Computer Systems | 3 | 2007 | 9 | 0.200 |
Why?
|
| Phantoms, Imaging | 5 | 2010 | 96 | 0.190 |
Why?
|
| Rectum | 3 | 2010 | 50 | 0.180 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 1394 | 0.180 |
Why?
|
| Prostatic Neoplasms | 3 | 2011 | 270 | 0.170 |
Why?
|
| Ultrasonography | 5 | 2011 | 228 | 0.150 |
Why?
|
| Spectrophotometry | 1 | 2018 | 34 | 0.150 |
Why?
|
| Needles | 1 | 2018 | 26 | 0.150 |
Why?
|
| Liver Cirrhosis | 1 | 2018 | 67 | 0.150 |
Why?
|
| Transducers | 3 | 2008 | 6 | 0.150 |
Why?
|
| Intraoperative Period | 1 | 2017 | 21 | 0.150 |
Why?
|
| Surface Properties | 1 | 2018 | 132 | 0.150 |
Why?
|
| Humans | 11 | 2018 | 26856 | 0.140 |
Why?
|
| Feasibility Studies | 3 | 2013 | 187 | 0.130 |
Why?
|
| Laparoscopy | 1 | 2017 | 143 | 0.130 |
Why?
|
| Avitaminosis | 1 | 2015 | 2 | 0.130 |
Why?
|
| Choline Deficiency | 1 | 2015 | 5 | 0.130 |
Why?
|
| Carboxy-Lyases | 1 | 2015 | 6 | 0.130 |
Why?
|
| Fourier Analysis | 2 | 2007 | 31 | 0.130 |
Why?
|
| In Vitro Techniques | 2 | 2014 | 239 | 0.130 |
Why?
|
| Systems Integration | 2 | 2005 | 3 | 0.130 |
Why?
|
| Subtraction Technique | 2 | 2005 | 8 | 0.120 |
Why?
|
| Biomarkers | 1 | 2018 | 731 | 0.120 |
Why?
|
| Adiposity | 1 | 2015 | 87 | 0.120 |
Why?
|
| Minerals | 1 | 2014 | 15 | 0.120 |
Why?
|
| Drug Liberation | 1 | 2014 | 23 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 537 | 0.110 |
Why?
|
| Proton Therapy | 1 | 2014 | 28 | 0.110 |
Why?
|
| Pancreatic Diseases | 1 | 2013 | 13 | 0.110 |
Why?
|
| Rats | 2 | 2015 | 1536 | 0.110 |
Why?
|
| Magnetic Fields | 1 | 2013 | 4 | 0.110 |
Why?
|
| Liposomes | 1 | 2014 | 142 | 0.110 |
Why?
|
| Sound | 1 | 2013 | 22 | 0.110 |
Why?
|
| Hemoglobins | 2 | 2011 | 116 | 0.110 |
Why?
|
| Radiation Dosage | 1 | 2013 | 53 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 472 | 0.100 |
Why?
|
| Male | 6 | 2015 | 12866 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 465 | 0.090 |
Why?
|
| Hypoxia | 1 | 2011 | 85 | 0.090 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 1259 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2010 | 128 | 0.080 |
Why?
|
| Pelvic Neoplasms | 1 | 2009 | 8 | 0.080 |
Why?
|
| Pelvis | 1 | 2009 | 37 | 0.080 |
Why?
|
| Neoplasm Transplantation | 1 | 2009 | 88 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 656 | 0.080 |
Why?
|
| Nails | 1 | 2007 | 2 | 0.070 |
Why?
|
| Reference Values | 1 | 2007 | 198 | 0.070 |
Why?
|
| Coronary Vessels | 1 | 2007 | 151 | 0.070 |
Why?
|
| Catheters, Indwelling | 1 | 2005 | 19 | 0.060 |
Why?
|
| Microscopy, Polarization | 1 | 2005 | 3 | 0.060 |
Why?
|
| Dental Enamel | 1 | 2005 | 5 | 0.060 |
Why?
|
| Dental Caries | 1 | 2005 | 21 | 0.060 |
Why?
|
| Dentin | 1 | 2005 | 12 | 0.060 |
Why?
|
| Tooth | 1 | 2005 | 15 | 0.060 |
Why?
|
| Rabbits | 1 | 2005 | 272 | 0.060 |
Why?
|
| Radiopharmaceuticals | 1 | 2005 | 68 | 0.060 |
Why?
|
| Ultrasonography, Mammary | 1 | 2004 | 3 | 0.060 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2004 | 16 | 0.060 |
Why?
|
| Psoas Muscles | 1 | 2024 | 2 | 0.060 |
Why?
|
| Abdomen | 1 | 2004 | 41 | 0.060 |
Why?
|
| Metmyoglobin | 1 | 2024 | 4 | 0.060 |
Why?
|
| Meat | 1 | 2024 | 10 | 0.060 |
Why?
|
| Color | 1 | 2024 | 22 | 0.060 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2004 | 68 | 0.060 |
Why?
|
| Beta Particles | 1 | 2003 | 1 | 0.060 |
Why?
|
| Lip | 1 | 2003 | 9 | 0.060 |
Why?
|
| Neoplasms | 1 | 2011 | 756 | 0.050 |
Why?
|
| Microcirculation | 1 | 2003 | 111 | 0.050 |
Why?
|
| Cattle | 1 | 2024 | 383 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2004 | 441 | 0.040 |
Why?
|
| Doxorubicin | 1 | 2014 | 74 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2014 | 87 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 290 | 0.030 |
Why?
|
| Temperature | 1 | 2014 | 207 | 0.030 |
Why?
|
| Cell Survival | 1 | 2014 | 393 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2011 | 59 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2011 | 49 | 0.020 |
Why?
|
| Oxyhemoglobins | 1 | 2011 | 10 | 0.020 |
Why?
|
| Water | 1 | 2011 | 131 | 0.020 |
Why?
|
| Female | 2 | 2004 | 14462 | 0.020 |
Why?
|
| Chickens | 1 | 2008 | 59 | 0.020 |
Why?
|
| Disease Progression | 1 | 2010 | 450 | 0.020 |
Why?
|
| Time Factors | 1 | 2009 | 1564 | 0.020 |
Why?
|
| Online Systems | 1 | 2004 | 11 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2004 | 38 | 0.010 |
Why?
|
| Catheterization | 1 | 2003 | 50 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 2003 | 67 | 0.010 |
Why?
|
| Mice | 1 | 2011 | 4402 | 0.010 |
Why?
|
| Middle Aged | 1 | 2004 | 6825 | 0.010 |
Why?
|